Leucovorin for the Treatment of 5 q Minus Syndrome

NCT00004997 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

NIH

Sponsor class

Conditions

5q Minus Syndrome
Myelodysplastic Syndrome

Interventions

DRUG: Leucovorin

Sponsor

National Institutes of Health Clinical Center (CC)